pharmaceutical industry

See the following -

Is Big Pharma Standing In The Way Of Curing The New SARS?

Alexander Abad-Santos | Nextgov | May 30, 2013

Middle East Respiratory Symptom coronavirus (MERS-CoV), better known as the new SARS cousin that is efficiently killing people in Saudi Arabia, has been described by the World Health Organization as "a threat to the entire world." Read More »

Is Big Pharma Standing In The Way Of Curing The New SARS?

Alexander Abad-Santos | Atlantic Wire | May 29, 2013

Middle East Respiratory Symptom coronavirus (MERS-CoV), better known as the new SARS cousin that is efficiently killing people in Saudi Arabia, has been described by the World Health Organization as "a threat to the entire world."... Read More »

Is Shkreli the Exception, or the Norm, in Big Pharma?

I didn't want to write about pharmaceutical companies.  They get enough bad press, and adding to it almost seems like piling on.  If Valeant is the poster company for outrage about drug pricing, it's less because what they are doing is unusual than it is because we suspect they are the norm. Honestly, I wanted to discuss McDonald's turning their Happy Meals boxes into VR headsets --I'm not making that up -- but, gosh darn it, it's almost like the pharmaceutical companies are daring me to talk about them.  So I will.

Read More »

Is The Patient Centered Outcomes Research Institute Really More Industry-Centered?

Roy M. Poses | Health Care Renewal | May 31, 2013

One of the biggest reasons our health care system seems so dysfunctional is that clinicians and patients have great difficulty determining what might be the appropriate management of particular clinical problems... Read More »

Is The Pharmaceutical Industry Doing Enough To Increase Access To Essential Medicines?

Charles Moore | Bio News Texas | April 8, 2014

A report in The Lancet Global Health journal, citing the World Health Organization’s World Medicines Situation, notes that despite progress in many countries, about a third of the world’s population still has no regular access to essential medicines, and says responsibility to resolve this problem lies with many, including the pharmaceutical industry.

Read More »

Italian Man Makes Worldwide Plea For Best Brain Cancer Treatment

Staff Writer | CTV News | November 18, 2012

Salvatore Iaconesi is looking for a cure for his brain cancer and he’s asking the world to help. Read More »

It’s Time To Change American Disease-Management Into A Health-Fostering System

Joseph Mercola | Mercola.com | March 18, 2013

I’ve recently written a couple of articles about the exorbitant cost of medical care in the US, which is incompatible with the poor health outcomes of Americans at large. Americans pay the most for but reap the least amount of benefits from their health care, compared to other industrialized nations... Read More »

J&J, Roche And Others Back Tech Platform To Bolster Translational Drug Research

Ryan McBride | FierceBiotechIT | April 10, 2013

Pharma experts and academics have joined forces to support an existing platform for managing digital translational research data, and their efforts could boost the plodding pace of drug research. The tranSMART Foundation incorporated as a nonprofit last week to organize the open source effort, Roche's ($RHHBY) Michael Braxenthaler, who serves as co-CEO of the foundation, told FierceBiotech IT. Read More »

Japanese Drugmakers Open 'Libraries' In $100 Million Health Project

Ben Hirschler | Reuters | May 30, 2013

Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientists hunting new treatments for malaria, tuberculosis and other diseases affecting the world's poor. Read More »

Kaiser Permanente Research Method Has Potential To Transform U.S. Health Care System

Sandy Kleffman | MercuryNews.com | June 10, 2013

It was a nuisance and David Gassman put it off for three weeks, but he finally put a little stool sample into a tube and mailed it to a Kaiser Permanente lab. It's a good thing he did. The test indicated he had colon cancer. Read More »

Largest Cancer Gene Database Made Public

Deena Beasley | MedlinePlus | July 15, 2013

National Cancer Institute scientists have released the largest-ever database of cancer-related genetic variations, providing researchers the most comprehensive way so far to figure out how to target treatments for the disease. Read More »

Let’s Build A Drug! Biopharma Startup Launches Crowdsourcing Tool To Pick Compounds

Stephanie Baum | MedCity News | October 24, 2012

A biopharma startup believes that when it comes to deciding what conditions it should develop drugs to treat, the decision should be left to a public vote. Read More »

Let’s Fight Big Pharma’s Crusade To Turn Eccentricity Into Illness

Allen Frances | Wired | May 17, 2013

Nature takes the long view, mankind the short. Nature picks diversity; we pick standardization. We are homogenizing our crops and homogenizing our people. And Big Pharma seems intent on pursuing a parallel attempt to create its own brand of human monoculture. Read More »

Mainstreaming ME Research: The 8th Invest In ME International ME Conference, 2013

Mark Berry | Phoenix Rising | June 2, 2013

Mark Berry reports from London on the 8th Invest in ME International ME Conference. Read More »

Members Of Congress: India's Pharma Industry 'Protectionism' Is Harming US Pharma Industry's Abuse Of Patent System

Tim Cushing | Techdirt | July 2, 2013

We recently discussed the US Chamber of Commerce's incredibly strange statement on the state of India's IP protection (or lack thereof). The CofC first applauded the success of India's Bollywood industry, achieved without strong IP protection, before insisting the only way it would survive was by implementing strong IP protection. Read More »